As the 18th Annual International Society for Pharmacoecomoics and Outcomes Research (ISPOR) begins this past weekend, today the Healthcare Economist examines drug prices around the world. Drug prices in the U.S. are much higher than any other developed country. This finding is robust whether the price index is created using the U.S. drug consumption basket or each countries own basket; whether the price index uses manufacturers or retail prices.
- Panos Kanavos, Alessandra Ferrario, Sotiris Vandoros, and Gerard F. Anderson. Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs. Health Affairs: 32, NO. 4 (2013): 10.1377/hlthaff.2012.0920.